One giant leap for cephalexin dosing, one small step for antimicrobial stewardship
- PMID: 36617614
- DOI: 10.1007/s43678-022-00442-6
One giant leap for cephalexin dosing, one small step for antimicrobial stewardship
Keywords: Cellulitis; Cephalexin; Emergency department; Pharmacokinetics.
References
-
- Dyar OJ, Huttner B, Schouten J, Pulcini C. What is antimicrobial stewardship? Clin Microbiol Infect. 2017;23:793–8. - DOI
-
- Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis. 1998;26:1–10. - DOI
-
- Everts RJ, Gardiner SJ, Zhang M, et al. Probenecid effects on cephalexin pharmacokinetics and pharmacodynamics in healthy volunteers. J Infect. 2021;83:182–9. - DOI
-
- Yadav K. 2022 High-Dose Cephalexin for Cellulitis: A Pilot Randomized Controlled Trial. CJEM.
-
- Dalen D, Fry A, Campbell SG, Eppler J, Zed PJ. Intravenous cefazolin plus oral probenecid versus oral cephalexin for the treatment of skin and soft tissue infections: a double-blind, non-inferiority, randomised controlled trial. Emerg Med J. 2018;35:492–8. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
